Radiosensitization by gold nanoparticles: Effective at megavoltage energies and potential role of oxidative stress

Translational Cancer Research

Volumn 2, Issue 4, 2013, Pages 269-279

  Butterworth, Karl T ^a   McMahon, Stephen J ^a   Taggart, Laura E ^a   Prise, Kevin M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Drug delivery; Gold nanoparticles (GNPs); Image contrast; Radiation; Radiosensitizer

Indexed keywords

EID: 84962720344     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2013.08.03     Document Type: Article

References (70)

1. Hubbell JH, Seltzer SM. Tables of X-ray Mass Attenuation coefficients and mass energy-absorption coefficients from 1 keV to 20MeV for Elements Z=1-92 and 48 Additional Substances of Dosimetric Interest, National Institute of Standards and Technology, US Department of Commerce, Gaithersburg, MD 20899, 1996.
2. Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-84.
3. Hainfeld JF, Slatkin DN, Focella TM, et al. Gold nanoparticles: a new X-ray contrast agent. Brit J Radiol 2006;79:248-53.
4. Hainfeld JF, O'Connor MJ, Dilmanian FA, et al. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Brit J Radiol 2011;84:526-33.
5. Reuveni T, Motiei M, Romman Z, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine 2011;6:2859-64.
6. Chanda N, Kattumuri V, Shukla R, et al. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A 2010;107:8760-5.
7. Jadzinsky PD, Calero G, Ackerson CJ, et al. Structure of a thiol monolayer-protected gold nanoparticle at 1.1 A resolution. Science 2007;318:430-3.
8. Vigderman L, Zubarev ER. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv Drug Deliv Rev 2013;65:663-76.
9. Langer R. Drug delivery and targetting. Nature 1998;392:5-10.
10. Mout R, Moyano FD, Rana S, et al. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 2012;41:2539-44.
11. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007;7:573-84.
12. Dhar S, Daniel WL, Giljohann DA, et al. J Am Chem Soc 2009;131:14652-3.
13. Comenge J, Sotelo C, Romero F, et al. Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin. PLoS One 2012;7:e47562.
14. Patra CR, Bhattacharya R, Mukhopadhyay D, et al. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 2010;62:346-61.
15. Brown SD, Nativo P, Smith JA, et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010;132:4678-84.
16. Gibson JD, Khanal BP, Zubarev ER. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 2007;129:11653-61.
17. Wang F, Wang YC, Dou S, et al. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 2011;5:3679-92.
18. Zhang XQ, Xu X, Lam R, et al. Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates. ACS Nano 2011;5:6962-70.
19. Dreaden EC, Mwakwari SC, Sodji QH, et al. Tamoxifen-poly(ethylene glycol)-Thiol gold nanoparticle conjugates: Enhanced potencu and selective delivery for breast cancer treatment. Bioconjug Chem 2009;20:2247-53.
20. Patra CR, Bhattacharya R, Wang E, et al. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res 2008;68:1970-8.
21. Heo DN, Yang DH, Moon HJ, et al. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012;33:856-66.
22. Henke G, Paulsen F, Steinbach JP, et al. Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol 2009;185:113-9.
23. Buie L, Valgus J. Current treatment options for the management of malignant glioma. Hematol Oncol Pharm 2012;5:57-63.
24. Orza A, Soriţău O, Tomuleasa C, et al. Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles. Int J Nanomedicine 2013;8:689-702.
25. Castillo MH, Button TM, Doerr R, et al. Effects of radiotherapy on mandibular reconstruction plates. Am J Surg 1988;156:261-3.
26. Allal AS, Richter M, Russo M, et al. Dose variation at bone/titanium interfaces using titanium hollow screw osseointegrating reconstruction plates. Int J Radiat Oncol Biol Phys 1998;40:215-9.
27. Niroomand-Rad A, Razavi R, Thobejane S, et al. Radiation dose perturbation at tissue-titanium dental interfaces in head and neck cancer patients. Int J Radiat Oncol Biol Phys 1996;34:475-80.
28. Regulla D, Schmid E, Friedland W, et al. Enhanced values of the RBE and H ratio for cytogenetic effects induced by secondary electrons from an X-irradiated gold gurface. Radiat Res 2002;158:505-15.
29. Herold DM, Das IJ, Stobbe CC, et al. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol 2000;76:1357-64.30.
30. Butterworth KT, Coulter JA, Jain S, et al. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology 2010;21:295101.
31. Chang MY, Shiau AL, Chen YH, et al. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci 2008;99:1479-84.
32. Chien C, Wang C, Hua T, et al. Synchrotron Radiation Instr 2006:1908-11.
33. Chithrani DB, Jelveh S, Jalali F, et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 2010;173:719-28.
34. Coulter JA, Jain S, Butteworth KT, et al. Cell dependent uptake and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine 2012;7:2673-85.
35. Geng F, Song K, Xing JZ, et al. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology 2011;22:285101.
36. Jain S, Coulter JA, Hounsell AR, et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys 2011;79:531-9.
37. Kong T, Zeng J, Wang X, et al. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 2008;4:1537-43.
38. Liu CJ, Wang CH, Chen ST, et al. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 2010;55:931-45.
39. Rahman WN, Bishara N, Ackerly T, et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine 2009;5:136-42.
40. Roa W, Zhang X, Guo L, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009;20:375101.
41. Zhang X, Xing JZ, Chen J, et al. Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin Invest Med 2008;31:E160-7.
42. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004;49:N309-15.
43. Hainfeld JF, Dilmanian FA, Zhong Z, et al. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 2010;55:3045-59.
44. Hainfeld JF, Smilowitz HM, O'Connor MJ, et al. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond) 2012. [Epub ahead of print].
45. Hebert EM, Debouttiere PJ, Hunting DJ, et al. MRI detectable gadolinium-coated gold nanoparticles for radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:S715-6.
46. Kim JK, Seo SJ, Kim KH, et al. Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect. Nanotechnology 2010;21:425102.
47. Kim JK, Seo SJ, Kim HT, et al. Enhanced proton treatment in mouse tumors through proton irradiated nanoradiator effects on metallic nanoparticles. Phys Med Biol 2012;57:8309-23.
48. Bahreyni Toossi MT, Ghorbani M, Mehrpouyan M, et al. A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles. Australas Phys Eng Sci Med 2012;35:177-85.
49. Ngwa W, Korideck H, Kassis AI, et al. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine 2013;9:25-7.
50. Cho SH. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol 2005;50:N163-73.
51. Robar JL. Generation and modelling of megavoltage photon beams for contrast-enhanced radiation therapy. Phys Med Biol 2006;51:5487-504.
52. Robar JL, Riccio SA, Martin MA. Tumour dose enhancement using modified megavoltage photon beams and contrast media. Phys Med Biol 2002;47:2433-49.
53. McMahon SJ, Mendenhall MH, Jain S, et al. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys Med Biol 2008;53:5635-51.
54. Garnica-Garza HM. Contrast-enhanced radiotherapy: feasibility and characteristics of the physical absorbed dose distribution for deep-seated tumors. Phys Med Biol 2009;54:5411-25.
55. Kappus H, Bothe D, Mahmutoglu I. The role of reactive oxygen species in the antitumor activity of bleomycin. Free Radic Res Commun 1990;11:261-6.
56. Mahmutoglu I, Scheulen ME, Kappus H. Oxygen radical formation and DNA damage due to enzymatic reduction of bleomycin-Fe(III). Arch Toxicol 1987;60:150-3.
57. Wallach-Dayan SB, Izbicki G, Cohen PY, et al. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 2006;290:L790-6.
58. Ott M, Gogvadze V, Orrenius S, et al. Mitochondria, oxidative stress and cell death. Apoptosis 2007;12:913-22.
59. Li JJ, Hartono D, Ong CN, et al. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010;31:5996-6003.
60. Pan Y, Leifert A, Ruau D, et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009;5:2067-76.
61. Chompoosor A, Saha K, Ghosh PS, et al. The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. Small 2010;6:2246-9.
62. Gao W, Xu K, Ji L, et al. Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicol Lett 2011;205:86-95.
63. Zhang XD, Wu D, Shen X, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012;33:6408-19.
64. Wu YN, Yang LX, Shi XY, et al. The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. Biomaterials 2011;32:4565-73.
65. Tournebize J, Boudier A, Joubert O, et al. Impact of gold nanoparticle coating on redox homeostasis. Int J Pharm 2012;438:107-16.
66. Menchón C, Martín R, Apostolova N, et al. Gold nanoparticles supported on nanoparticulate ceria as a powerful agent against intracellular oxidative stress. Small 2012;8:1895-903.
67. Carter JD, Cheng NN, Qu Y, et al. Nanoscale energy deposition by X-ray absorbing nanostructures. J Phys Chem B 2007;111:11622-5.
68. Misawa M, Takahashi J. Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. Nanomedicine 2011;7:604-14.
69. Libutti SK, Paciotti GF, Byrnes AA, et al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 2010;16:6139-49.
70. Joh DY, Sun L, Stangl M, Al Zaki A, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One 2013; 30;8:e62425.